Form 4: Procept BioRobotics Director Thomas Krummel Sells Shares Under 10b5-1 Plan

Director Thomas Krummel sold shares of Procept BioRobotics Corp (PRCT) on March 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Thomas M. Krummel, a director of Procept BioRobotics Corp (PRCT), sold shares of the company's common stock on March 4, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on November 18, 2023.
• Two transactions occurred: the first involved the sale of 11,762 shares at a weighted average price of $48.2111, and the second involved the sale of 8,238 shares at a weighted average price of $48.9905.
• Following these transactions, Krummel directly owns 65,631 shares of Procept BioRobotics Corp.
• The reporting person will provide full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnotes upon request.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for corporate insiders to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on material non-public information.

Stakeholder Impact

• The stock sale by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates